Inside this issue
Highlighted signals and events
During epidemiological week 33 (10 August to 16 August 2026), WHO Public Health Intelligence (PHI) teams conducted digital event‑based surveillance (DEBS) to support the early detection and assessment of potential public health threats. During the reporting period, approximately 627 661 raw signals were scanned and triangulated through DEBS. From this large pool of signals, 20 signals and/or events met assessment thresholds and underwent further analysis and categorization. Of the 20 categorized signals, all 20 represented unique signals. 14 signals and/or events were escalated for operational attention.
In the reporting week, two new events were verified through PHI activities. One Disease Outbreak News was published during this reporting week. A summary of identified raw signals, assessed signals, and published outputs is presented in the tables below.
| Screened signals1 | Signals categorized2 | Unique signals3 | Signals escalated4 |
| 627 661 | 20 | 20 | 14 |
1 Signals screened: Total volume of raw signals reviewed from across multiple sources during the reporting period.
2 Signals categorized: Number of signals categorized for further detailed WHO assessment and actions during the reporting period.
3 Unique signals: Count of distinct signals after removing duplicate or repeated entries from different sources within the same epidemiological week.
4 Signals escalated: Subset of categorized signals that triggered escalation actions.
| Region | Hazard |
| Africa | • Cholera • Diphtheria •Lassa fever •Rift Valley fever •Zika virus disease |
| Americas | • Myiasis • Yellow fever |
| Eastern Mediterranean | • Vaccine-derived poliovirus 2,(environmental) |
| Europe | • Andes hantavirus • Anthrax |
| South-East Asia | • Cholera • Not yet diagnosed disease |
| Western Pacific | • Influenza due to identified avian or animal Influenza virus |
5 The absence of listed signals indicates that no publicly available signals were identified during the reporting period and does not imply absence of signal activity overall. Signals designated as “Not yet diagnosed” refer to those with ongoing epidemiological and clinical investigations to determine the causative hazard or disease.
6 Only new events registered during the defined period are included, accordingly changes to disease/condition that occur after the data cut-off of 23:59 on 16 August 2026 will not be reflected in the description. The absence of events indicates that no publicly available newly reported events were identified during the reporting period and does not imply absence of event activity overall.
| Disease Outbreak News (1) | |
| • | Ebola disease caused by Bundibugyo virus - Democratic Republic of the Congo |
The 2026 Bundibugyo virus disease outbreak in the Democratic Republic of the Congo in context: lessons from previous outbreaks
Bundibugyo virus disease (BVD), caused by the Bundibugyo virus (BDBV), is one of the ebolavirus diseases known to cause outbreaks in humans. BDBV was first recognized as a cause of human disease during an outbreak in Bundibugyo District, western Uganda, in 2007. Since then, only two further BVD outbreaks have been documented: an outbreak in the Isiro area of Haut-Uélé, north-eastern Democratic Republic of the Congo in 2012, and the ongoing outbreak declared in May 2026 and centred on Ituri Province, Democratic Republic of the Congo.
The current outbreak differs from the two earlier BVD outbreaks in size, spread and the conditions in which the response is operating. A comparison of the three outbreaks demonstrates what progress has made in identification and confirmation and what has not—notably the time taken to recognize and confirm transmission.
Uganda (2007–2008)
The first recognized outbreak of BVD occurred in Bundibugyo District, a predominantly rural district in western Uganda bordering the Democratic Republic of the Congo and situated near the Semliki National Park and wildlife reserve. Although the initial introduction was presumed to have involved wildlife exposure, the source of zoonotic transmission was not established. Transmission remained highly localized: more than 97% of probable and confirmed cases occurred in four of the district’s 10 subcounties, with no sustained transmission documented outside Bundibugyo District.1
By the end of the outbreak in February 2008, 93 putative and 56 laboratory-confirmed cases had been reported, with 37 deaths, corresponding to an overall reported case fatality ratio (CFR) of 25%. CFR estimates among laboratory-confirmed cases were approximately 40%. Among confirmed cases, the median age was 37.4 years and 54% were male.2,3
Isiro, Democratic Republic of the Congo (2012)
The second documented BVD outbreak occurred in 2012 in the Isiro area of Haut-Uélé, north-eastern Democratic Republic of the Congo. In contrast to the predominantly rural setting of the 2007 outbreak, Isiro was a regional urban and mining centre with an established health-care referral network. Nevertheless, transmission remained geographically localized, principally in Isiro with a secondary focus in Viadana, approximately 75 km to the south-west.4
The outbreak lasted approximately four months and was declared over on 26 November 2012. A total of 62 cases were reported, including five suspected, 21 probable and 36 confirmed cases, with 34 deaths, corresponding to a crude CFR of 54.8%. Among laboratory-confirmed cases, the CFR was approximately 34%. Among 52 cases included in a detailed analysis, the majority were female: 85% of community cases and 61% of cases treated at the Ebola treatment centre were female.5,6
Ituri and eastern Democratic Republic of the Congo (2026)
The ongoing outbreak is unprecedented in scale among Ebola outbreaks reported in the Democratic Republic of the Congo. As of 16 August 2026, 5021 confirmed cases and 2378 confirmed deaths had been reported. The confirmed-case count alone had already exceeded the combined published case totals of the 16 previous Ebola outbreaks documented in the country (approximately 4800 cases in aggregate), although historical case definitions and classifications were not fully standardized.7,8,9 Approximately 85% of reported cases remain concentrated in Ituri Province, but transmission has expanded to 56 health zones across six provinces: Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo and Bas-Uélé. Cross-border spread also occurred, with 15 imported cases and five secondary cases reported in Uganda and one imported case detected in France. Reported case counts underestimate the true burden, although the extent of under-ascertainment remains uncertain.7,8
Adults aged 18–49 years have accounted for the largest proportion of reported cases, with broadly similar numbers among men and women overall. At least 155 health-care workers had been infected by mid-August, indicating continued occupational and health-care-associated exposure.8
Difference in Outbreak Setting
The three outbreaks occurred in very different settings. In 2007, transmission remained concentrated in a rural, mountainous border district. Bundibugyo had experienced displacement related to armed group activity in earlier years, but insecurity was not described as a major constraint on the Ebola response itself. 1,10 In 2012, Isiro was an urban and mining centre in a region with a history of violence, displacement and poor transport links, but similarly, insecurity was not considered as a main barrier to the response.
The 2026 outbreak is currently unfolding in a different environment. The area where the outbreak is thought to have started, Mongbwalu, is a busy gold-mining area with frequent movement of workers and traders, while Ituri’s capital city of Bunia is a major commercial centre and health-care referral hub. Roads, rivers and mining routes connect affected communities across eastern Democratic Republic of the Congo and with neighboring countries. At the same time, the region is struggling with a humanitarian crisis, with insecurity and displacement throughout the region facilitating disease transmission while simultaneously stymying response activities.11,8
The setting matters when considering delay. A few weeks of unrecognized transmission in a relatively contained setting do not carry the same risk as the same delay in a highly mobile, multi-province network where response teams may also struggle to reach affected communities.
Delays in Recognition and Confirmation
All three outbreaks have involved a period of transmission before formal recognition, but where in the process that delay occurred and the extent of that delay vary between outbreaks.
In the 2007 Uganda outbreak, an initial alert following cases of febrile diarrheal illness was raised on 2 August, but the investigation was inconclusive. A second alert was raised on 5 November after 20 deaths had occurred in Bundibugyo District. BDBV was confirmed 24 days later, on 29 November, as a previously unknown ebolavirus species. Overall, approximately 119 days separated the first alert and confirmation, reflecting both the difficulty in recognizing the event after the initial signal and the time needed to identify a new virus.12,1
By the time of the 2012 outbreak in Isiro, the pathogen was known and laboratory confirmation was faster. Yet, recognizing the outbreak remained difficult, as BVD can resemble common febrile illnesses, including malaria. A cluster of unexplained deaths eventually triggered an alert on 2 August 2012. Retrospective investigation linked the earliest laboratory-confirmed case to symptom onset on 28 June, indicating at least 35 days of unrecognized transmission before the alert. Laboratory confirmation followed 14 days later, on 16 August, and the outbreak was declared the following day. Compared with 2007, confirmation was faster; the main delay had shifted to recognizing and escalating the event.4,6
In 2026, the delay before recognition is hard to determine. A phylogenetic analysis of 139 BDBV genomes estimated the time to most recent common ancestor to be in early to mid-March 2026, suggesting that the virus may have been circulating since early to mid-March, several weeks before the alert on 5 May. Anthropological research [unpublished] has suggested an even earlier start. Once the alert was raised, confirmation took 10 days. Initial GeneXpert testing for Zaire ebolavirus was negative, and broader pan-Orthoebolavirus testing and sequencing at INRB Kinshasa were needed for confirmation. This again points to two issues: recognizing and reporting unusual transmission early and ensuring that negative species-specific tests trigger broader testing quickly.11,13
The figure shows a clear shift. Confirmation became faster over time, but recognition remained a recurring problem. In the ongoing 2026 outbreak, that delay occurred in a setting with far greater mobility and with insecurity directly affecting response operations, making the consequences potentially much greater.

Implications for Surveillance and Response
Faster laboratory testing and confirmation alone are not sufficient. Surveillance systems must also prioritize the rapid detection and reporting of early evidence of transmission. In all three outbreaks, the time before recognition delayed the response that followed. Clusters of unexplained deaths and illness among health-care workers, observed in these outbreaks, warrant investigation as potential early signals rather than retrospective explanation. When such signals recur, they should trigger faster identification, allowing response activities to begin as soon as possible.
The 2026 outbreak also illustrates why diagnostic algorithms need to look beyond Zaire ebolavirus when initial testing is negative. Unlike in 2007, when Bundibugyo virus was an unrecognized pathogen, BVD is now a known and characterized disease. Faster identification and laboratory confirmation of BVD will trigger a more rapid response.
The current outbreak is therefore not simply a larger version of the two earlier BVD outbreaks. It is the same virus spreading in a different environment. The earlier outbreaks show that delays in recognition are not new, but the 2026 shows how much more consequential such delays can become when transmission occurs across highly connected populations during an active humanitarian emergency.
1 Wamala JF, Lukwago L, Malimbo M, et al. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007–2008. Emerg Infect Dis. 2010;16(7):1087–1092.
2 Roddy P, Howard N, Van Kerkhove MD, et al. Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007–2008. PLoS One. 2012;7(12):e52986.
3 MacNeil A, Farnon EC, Wamala J, et al. Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis. 2010;16(12):1969–1972.
4 WHO Regional Office for Africa. Rapport de Situation – Préparation et Réponse aux Urgences, Edition du 12 septembre 2012. Isiro outbreak update and Viadana secondary focus.
5 Kratz T, Roddy P, Tshomba Oloma A, et al. Ebola virus disease outbreak in Isiro, Democratic Republic of the Congo, 2012: signs and symptoms, management and outcomes. PLoS One. 2015;10(6):e0129333.
6 Hulseberg CE, Kugelman JR, Palacios G, et al. Molecular analysis of the 2012 Bundibugyo virus disease outbreak. Cell Rep Med. 2021;2:100351.
7 WHO Regional Office for Africa. Ebola Bundibugyo virus disease outbreak, Democratic Republic of the Congo | Uganda. Weekly External Situation Report 14; data as of 16 August 2026.
8 World Health Organization. Ebola disease caused by Bundibugyo virus – Democratic Republic of the Congo. Disease Outbreak News. 14 August 2026. DON615.
9 Centre s for Disease Control and Prevention. History of Ebola outbreaks. Updated 29 May 2026. Historical published case totals for the 16 Democratic Republic of the Congo outbreaks preceding the 2026 event sum to 4 816 cases; classifications varied between outbreaks.
10 IRIN (UN Office for the Coordination of Humanitarian Affairs). Uganda: IRIN Special Report on the ADF rebellion. 8 December 1999.
11 World Health Organization. Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda. Disease Outbreak News. 16 May 2026. DON602.
12 Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S, et al. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008;4:e1000212.
13 Amuri-Aziza A, Adroba Tandele P, Paku-Tshambu P, et al. Genomic epidemiology of the ongoing 2026 Bundibugyo virus disease outbreak in the Democratic Republic of the Congo. Virological.org. Posted 9 July 2026.



